Development of orally active novel anti-cancer compounds targeting p53

Reference number
Coordinator Aprea AB
Funding from Vinnova SEK 1 065 310
Project duration June 2010 - November 2012
Status Completed

Last updated 25 November 2019

Reference number 2010-00386

Page statistics